BELLO, LORENZO
BELLO, LORENZO
Dipartimento di Oncologia ed Emato-Oncologia
Single-cell analysis reveals corticosteroid-associated impairment of tumor-infiltrating NK cells in glioblastoma patients
2026 S. Balin, P. Marzano, A. Limonta, S. Terzoli, M. Simonelli, L. Bello, F. Pessina, B. Savino, J. Mikulak, F. Calcaterra, E. Fontana, M. Locati, D. Mavilio, S. Della Bella
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 2: perioperative recommendations for neurological, language, functional, and quality-of-life assessment
2026 J.K.W. Gerritsen, P. Karschnia, L. Bello, S. Hervey-Jumper, J.S. Young, K. Seidel, D.D. Satoer, O. Schnell, M. Parsons, B.V. Nahed, G. Menna, N. Teske, T.R. Smith, N. Sanai, S.M. Krieg, P. Schucht, M.L.D. Broekman, S. De Vleeschouwer, A.S. Jakola, M.J. Van Den Bent, S.M. Chang, M.A. Vogelbaum, A.J.P.E. Vincent, J. Tonn, M.S. Berger
Towards more effective Glioblastoma Multiforme therapies: HDAC6 and HDAC8 combined targeting
2026 G. Galassi, S. Carbone, L. Brioschi, I. Tagliabue, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, M. Caterina Mione, L. Mollica, P. Viani, A. Pistocchi
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 1: intraoperative recommendations for mapping, monitoring, and decision making
2026 J.K.W. Gerritsen, P. Karschnia, L. Bello, S. Hervey-Jumper, J.S. Young, K. Seidel, D.D. Satoer, O. Schnell, M. Parsons, B.V. Nahed, G. Menna, N. Teske, T.R. Smith, N. Sanai, S.M. Krieg, P. Schucht, M.L.D. Broekman, S. De Vleeschouwer, A.S. Jakola, M.J. Van Den Bent, S.M. Chang, M.A. Vogelbaum, A.J.P.E. Vincent, J. Tonn, M.S. Berger
Automatic and standardized reporting of perioperative MRIs in patients with central nervous system tumors
2026 D. Bouget, M.G. Faanes, A.S. Jakola, F. Barkhof, H. Ardon, L. Bello, M.S. Berger, S.L. Hervey-Jumper, J. Furtner, A.J.S. Idema, B. Kiesel, G. Widhalm, R.N. Tewarie, E. Mandonnet, P.A. Robe, M. Wagemakers, T.R. Smith, P.C. De Witt Hamer, O. Solheim, I. Reinertsen
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect group
2025 P. Karschnia, J.S. Young, G.C. Youssef, A. Dono, L. Häni, T. Sciortino, F. Bruno, S.T. Juenger, N. Teske, J. Dietrich, M. Weller, M.A. Vogelbaum, M. Van Den Bent, J. Beck, N. Thon, J.K.W. Gerritsen, S. Hervey-Jumper, D.P. Cahill, S.M. Chang, R. Rudà, L. Bello, O. Schnell, Y. Esquenazi, M.I. Ruge, S.J. Grau, R.Y. Huang, P.Y. Wen, M.S. Berger, A.M. Molinaro, J. Tonn
White matter connections within the central sulcus subserving the somato-cognitive action network
2025 G.P. Skandalakis, L. Viganò, C. Neudorfer, M. Rossi, L. Fornia, G. Cerri, K.P. Kinsman, Z. Bajouri, A.D. Tavakkoli, C. Koutsarnakis, E. Lani, S. Komaitis, G. Stranjalis, G. Zadeh, J. Barrios-Martinez, F. Yeh, D. Serletis, M. Kogan, C.G. Hadjipanayis, J. Hong, N. Simmons, E.M. Gordon, N.U.F. Dosenbach, A. Horn, L. Bello, A. Kalyvas, L.T. Evans
HDAC6 and HDAC8 inhibition enhances the efficacy of Temozolomide by rewiring sphingolipid metabolism and glioma cell fate
2025 I. Tagliabue, L. Brioschi, G. Galassi, S. Carbone, A. Pezzotta, A. Marozzi, L. Mollica, L. Sicuro, L. Bello, G. Campiani, G. Carullo, M. Caterina Mione, A. Pistocchi, P. Viani
Towards more effective Glioblastoma Multiforme therapies: HDAC6 and HDAC8 combined targeting
2025 S. Carbone, G. Galassi, L. Brioschi, I. Tagliabue, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, M. Caterina Mione, L. Mollica, P. Viani, A. Pistocchi
Prognostic value of manual versus automatic methods for assessing extents of resection and residual tumor volume in glioblastoma
2025 P. Majewska, R. Holden Helland, A. Ferles, A. Pedersen, I. Kommers, H. Ardon, F. Barkhof, L. Bello, M.S. Berger, T. Dunås, M. Conti Nibali, J. Furtner, S.L. Hervey-Jumper, A.J.S. Idema, B. Kiesel, R. Nandoe Tewarie, E. Mandonnet, D.M.J. Müller, P.A. Robe, M. Rossi, T. Sciortino, T. Aalders, M. Wagemakers, G. Widhalm, A.H. Zwinderman, P.C. De Witt Hamer, R.S. Eijgelaar, L.M. Sagberg, A.S. Jakola, E. Thurin, I. Reinertsen, D. Bouget, O. Solheim
HDAC6 and HDAC8 orchestrate sphingolipid metabolic reprogramming to regulate glioma cell fate
2025 I. Tagliabue, L. Brioschi, G. Galassi, S. Carbone, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, L. Mollica, M.C. Mione, A. Pistocchi, P. Viani
HDAC8 and HDAC6 combined inhibition: a new frontier in glioblastoma treatment
2025 G. Galassi, S. Carbone, L. Brioschi, I. Tagliabue, A. Pezzotta, A. Marozzi, G. Carullo, L. Sicuro, L. Mollica, L. Bello, G. Campiani, P. Viani, M. Caterina Mione, A. Pistocchi
HDAC8 AND HDAC6 COMBINED INHIBITION: A NEW FRONTIER IN GLIOBLASTOMA TREATMENT
2025 S. Carbone, G. Galassi, L. Brioschi, I. Tagliabue, D. Giana, A. Pezzotta, A. Marozzi, G. Carullo, L. Sicuro, L. Mollica, L. Bello, G. Campiani, P. Viani, M.C. Mione, A. Pistocchi
Convergent causal mapping unravels distinct frontal networks for visuospatial selective attention
2025 G. Puglisi, L. Viganò, A. Leonetti, M. Rossi, T. Sciortino, M. Conti Nibali, L.G. Gay, L. Mollica, L. Fornia, G. Cerri, L. Bello
From non-human to human primates: a translational approach to enhancing resection, safety, and indications in glioma surgery while preserving sensorimotor abilities
2025 M. Gambaretti, L. Viganò, M. Gallo, G. Pratelli, T. Sciortino, L. Gay, M. Conti Nibali, A.L. Gallotti, L. Tariciotti, L. Mattioli, L. Bello, G. Cerri, M. Rossi
A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomas
2025 T. Chouleur, C. Etchegaray, L. Villain, A. Lesur, T. Ferté, M. Rossi, L. Andrique, C. Simoncini, A. Giacobbi, M. Gambaretti, E. Lopci, B. Fernades, G. Dittmar, R. Bjerkvig, B. Hejblum, R. Thiébaut, O. Saut, L. Bello, A. Bikfalvi
Estimating overall survival of glioblastoma patients using clinical variables, tumor size, and location
2025 A. Ferles, P. Majewska, R. Holden Helland, I. Kommers, A. Pedersen, M. Tranfa, H. Ardon, L. Bello, M.S. Berger, T. Dunås, M.C. Nibali, J. Furtner, S.L. Hervey-Jumper, A.J.S. Idema, B. Kiesel, R.N. Tewarie, E. Mandonnet, P.A. Robe, M. Rossi, T. Sciortino, T. Aalders, M. Wagemakers, G. Widhalm, A.H. Zwinderman, L.M. Sagberg, A.S. Jakola, E. Thurin, I. Reinertsen, D. Bouget, O. Solheim, R.S. Eijgelaar, P.C. De Witt Hamer, F. Barkhof
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
2025 P. Karschnia, J.S. Young, M.M.J. Wijnenga, T. Sciortino, N. Teske, A. Corell, A. Wagner, G. Youssef, Y.W. Park, L. Häni, S.T. Jünger, A. Dono, F. Ehret, E.E.M. Mireles, N. Neidert, F. Bruno, C.A. Tuchek, T. Van Der Vaart, M. Rossi, M.C. Nibali, L. Gay, A. Gramelt, N. Tandon, S.S. Ahn, J.H. Chang, M. Weller, A.J.P.E. Vincent, R. Goldbrunner, D.P. Cahill, R.Y. Huang, A. Raabe, B. Meyer, J. Beck, A.M. Molinaro, S.M. Chang, M.A. Vogelbaum, R. Rudà, E.O. Vik-Mo, J. Dietrich, Y. Esquenazi, S.J. Grau, P.Y. Wen, A.S. Jakola, O. Schnell, L. Bello, M.J. Van Den Bent, S. Hervey-Jumper, M.S. Berger, J. Tonn
Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With IDH1/2-Mutant Lower-Grade Glioma
2024 F. Bruno, A. Pellerino, M. Conti Nibali, E. Pronello, F. Cofano, M. Rossi, M. Levis, L. Bertero, R. Soffietti, P. Cassoni, D. Garbossa, L. Bello, R. Rudà
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease
2024 V. Pieri, G. Berzero, R. Paterra, L. Ferré, A. Tomelleri, C. Campochiaro, F. Esposito, T. Calimeri, M.G. Cangi, N.P. Tenace, A.J.M. Ferreri, A. Castellano, M. Barbera, N. Anzalone, L.G. Gay, L. Bello, M. Colecchia, M. Ponzoni, G. Finocchiaro, M. Filippi